Innovations that make a positive difference in patients’ lives
Leverages over 40 years of entrepreneurial experience across multiple sectors, we strategically invest in life sciences. With a focus on medical therapies that address unmet needs, M&L Healthcare seeks to be a leader in the development of transformative and sustainable healthcare solutions. Our commitment is grounded in sound clinical evidence and a mission to build a legacy that transcends financial return.
Wholly owned by Grandline International, and part of the M&L Group, M&L Healthcare embodies the Kum family’s philosophy of combining business expertise with a long-term vision to create meaningful impact. We target innovative healthcare applications that improve lives, aspiring to set new standards in medical technology and ethical investment.
OUR PORTFOLIO
A growing legacy of health and hope
Our portfolio focuses on pioneering investments in medical technology and life sciences, partnering with innovators who share our values of integrity, commitment, and diversity. By fostering collaborative, respectful relationships worldwide, M&L Healthcare positions itself to meet global healthcare challenges. With the resources and expertise of the M&L Group, we are poised to make a lasting difference in healthcare outcomes.
OUR PEOPLE
Empowering growth through diverse expertise and visionary leadership
M&L Healthcare is guided by a diverse Executive Team with extensive experience in investment management, finance and healthcare.
We focus on enhancing the value of M&L Healthcare through active investment management, strategic investment, and sound financial and expert practices.
Group news
What’s been happening across M&L Group